13 Tech Stocks with Big Promise

Nvidia

• Symbol: NVDA
• Share price: $109
• Market value: $58.9 billion
• Revenue: $6.1 billion
• Net income: $1.2 billion
• Est. 2017 earnings growth: 16.0%
• P/E ratio: 39

In the auto industry, the biggest potential gains belong to the companies supplying carmakers with artificial-intelligence brains, semiconductors and sensing technology. At the forefront of this trend is chip maker Nvidia. The company has long dominated the market for powerful graphics-processing chips that are used in computers and video-game systems. Now those processors are becoming hot sellers in the car market, too.

Fusing data from onboard sensors, cameras and laser-based systems, the firm’s new Drive PX 2 technology can “understand” a vehicle’s environment and help guide the car down the road. At full power, Nvidia says, the system can process “24 trillion deep learning operations per second”—enough AI brainpower to replace a human driver. Nvidia says Tesla plans to deploy this mini supercomputer in its vehicles, and other carmakers are buying versions of the technology.

Nvidia’s automotive sales amounted to $359 million for the nine-month period that ended last October—less than 10% of total sales, most of which come from gaming chips. But auto-related sales climbed 60% from a year earlier and should increase steadily as more carmakers buy Nvidia’s chips. Nvidia recently announced deals with Audi and Mercedes–Benz to include its technology in forthcoming models.

Qualcomm

• Symbol: QCOM
• Share price: $53
• Market value: $79.0 billion
• Revenue: $23.8 billion
• Net income: $6.2 billion
• Est. 2017 earnings growth: 19.0%
• P/E ratio: 11

Chip maker Qualcomm is racing into the auto industry, too. The firm’s Snapdragon lineup of processors runs “infotainment” systems and applications such as 3-D navigation. Qualcomm’s auto business could get a big lift, too, from its planned merger with NXP Semiconductors (NXPI), the world’s largest maker of automotive chips and sensors (the deal is expected to close later this year).

Outside its automotive business, Qualcomm makes chip sets for the wireless industry and earns hefty royalties from licensing CDMA technology—a critical component of wireless devices and mobile networks around the world. Qualcomm faces lawsuits and charges that its licensing practices are anti-competitive, and the stock tumbled 18% in January because of fears that the highly lucrative licensing business may not be as profitable in the future. If more legal issues arise, the stock could slump again.

Still, Qualcomm’s deal for NXP should be a big winner, helping to boost the firm’s sales and profits in the automotive space and other high-growth areas, such as security and networking. The company should also retain its “pole position” in wireless technology, says Sonu Kalra, manager of the Fidelity Blue Chip Growth Fund. Trading at just 11 times earnings, the stock looks inexpensive. As a bonus, the shares possess a healthy 4.0% dividend yield.

Broadcom

• Symbol: AVGO
• Share price: $200
• Market value: $84.2 billion
• Revenue: $13.2 billion
• Net income: $4.1 billion
• Est. 2017 earnings growth: 24.0%
• P/E ratio: 14

Built through a series of mergers, Broadcom sells a wide assortment of chips, sensors and other high-tech gear, much of it related to wireless communications, data storage and networking.

Those technologies are at the core of Internet of Things (IoT) — the vast world of digitally connected objects, from traffic signals to much more prosaic items, such as trash cans. Research firm Gartner estimates that 6.4 billion “things” were connected to the internet last year, up 30% from 2015. By 2020, Gartner estimates, the figure will rise to 20.8 billion. IDC Research sees spending on IoT-related goods and services jumping from $737 billion in 2016 to $1.29 trillion in 2020.

Broadcom sold some of its IoT-related technology to Cypress Semiconductor (CY) in 2016. But the deluge of data created by IoT devices is lifting demand for Broadcom’s products, especially from data centers, where companies are upgrading networking gear and computers to handle the digital flood. Broadcom is the 800-pound gorilla in data centers, says Paul Wick, comanager of the Columbia Seligman Communications and Information Fund. The firm’s profits are zooming, too.

Splunk

• Symbol: SPLK
• Share price: $58
• Market value: $7.9 billion
• Revenue: $0.9 billion
• Net income: -$0.3 billion
• Est. 2017 earnings growth: Profit expected in current year
• P/E ratio: 107

Software maker Splunk should also benefit from the IoT and related spending on cloud computing.

The firm’s software translates machine data into visual form, helping businesses identify and analyze digital trends in real time and diagnose problems in industrial networks. Customers pay Splunk based partly on the quantity of data coursing through its system, a setup that should lift revenues as more data flows through, says Morningstar analyst Rodney Nelson. Because Splunk is spending heavily to build its business, it isn’t profitable yet. But most of Splunk’s customers have moved only 20% to 25% of their machine data to Splunk’s system, estimates Bank of America Merrill Lynch. That should leave plenty of room for growth as the IoT expands and Splunk signs up more businesses.

Intuitive Surgical

• Symbol: ISRG
• Share price: $693
• Market value: $26.8 billion
• Revenue: $2.7 billion
• Net income: $0.8 billion
• Est. 2017 earnings growth: 24.0%
• P/E ratio: 14

A leader in the burgeoning field of robotic surgery, Intuitive Surgical has sold more than 3,800 of its da Vinci machines over the past 15 years. Physicians use the da Vinci’s arms to perform minimally invasive surgery, which usually is easier on patients and can be more precise than traditional operating techniques. Da Vinci is now used in more than 80% of prostate cancer surgeries in the U.S., and it’s being deployed for scores of other operations, such as hysterectomies and coronary bypasses. Intuitive estimates that more than 700,000 robotic medical procedures were conducted in 2016, an increase of about 15% from the previous year.

Despite that impressive growth, Intuitive isn’t close to saturating the market. The company launched a more advanced da Vinci system in 2014, expanding its potential uses and fueling sales growth as hospitals upgrade older systems. The company is also making money selling accessories and services, and it should continue to expand as doctors become more comfortable with the system and consumers increasingly request robotic surgery, says Fidelity fund manager Kalra.

Cognex

• Symbol: CGNX
• Share price: $68
• Market value: $5.8 billion
• Revenue: $0.5 billion
• Net income: $0.1 billion
• Est. 2017 earnings growth: 10.0%
• P/E ratio: 39

Another U.S. company riding the automation wave is Cognex. The firm makes machine-vision technology, such as cameras, lenses and software, for bar-code readers, industrial equipment and “vision-guided” robots. These sophisticated machines are playing a greater role in assembling cars, computer chips and other precision-engineered products, and they can take over dangerous industrial work, such as manipulating parts on a metal-cutting saw. Cognex recently bought two 3-D vision companies to boost sales in the automotive, electronics and logistics industries. Factory automation now accounts for more than 95% of its revenues, which are climbing steadily.

CyberArk Software

• Symbol: CYBR
• Share price: $53
• Market value: $1.8 billion
• Revenue: $0.2 billion
• Net income: $0.0 billion
• Est. 2017 earnings growth: 13.0%
• P/E ratio: 40

Behind the scenes at many big companies, a game of digital cat and mouse goes on day and night. Hackers try to breach a computer system, cybersecurity police chase them down, and the process repeats itself. With data breaches and cybertheft growing more prevalent, spending on security products is expected to rise steadily. CyberArk Software should thrive in this heightened-threat climate.

Based in Israel, the company sells software to thwart hackers who try to breach “privileged” accounts in corporate computing networks. Closely guarded in the digital world, these accounts often provide access to sensitive corporate data, holding the “keys to the IT kingdom,” as CyberArk puts it. If attackers do penetrate, CyberArk can lock down and isolate the accounts, preventing data theft or damage to corporate computer systems.Although the firm competes against much larger cybersecurity outfits, it dominates the privileged-account niche with a “unique” technology, says Columbia Seligman’s Wick. Analysts expect revenues to increase 22% this year and profits to climb almost 13%.

Check Point Software Technologies

• Symbol: CHKP
• Share price: $99
• Market value: $17.3 billion
• Revenue: $1.7 billion
• Net income: $0.7 billion
• Est. 2017 earnings growth: 21.0%
• P/E ratio: 19

Another Israeli firm, Check Point Software Technologies offers broader solutions to cyber threats. It sells bundles of devices and software to create “unified threat management” systems that, ideally, can protect an entire global network of computers, applications and data.

Check Point is now targeting small and midsize businesses with its cybersecurity bundles, and it’s expanding into areas such as “advanced threat protection” for mobile devices and “virtual” desktops—a burgeoning business as more employees work remotely.

Illumina

• Symbol: ILMN
• Share price: $160
• Market value: $23.5 billion
• Revenue: $2.4 billion
• Net income: $0.4 billion
• Est. 2017 earnings growth: 20.0%
• P/E ratio: 44
• llumina, the leading maker of gene-sequencing machines and related products, stands at the forefront of the DNA revolution.

Researchers are using its technology to investigate the genetics of people, microorganisms and diseases such as cancer, resulting in more-precise diagnoses and more-personalized treatments. Illumina is now launching a new generation of machines that it says will be able to sequence an entire human genome in less than 24 hours for as little as $100, a development that could vastly expand the technology’s reach. The company is also teaming up with firms such as IBM (IBM) and Dutch conglomerate Philips (PHG) to develop more medical diagnostic tools that should extend sales in the health care field.

Illumina’s growth isn’t a slam dunk. Sales could slump if labs curb spending on genetic testing and research. The company is battling rivals such as Thermo Fisher Scientific (TMO) and Qiagen (QGEN) in the gene-sequencing space. Illumina’s sales growth has slowed sharply in recent years, too. But don’t be discouraged, says Bank of America Merrill Lynch. Illumina now has “the pieces in place” to return to “mid teens” revenue growth by 2018, says Merrill, which rates the stock a buy.

BioMarin

• Symbol: BMRN
• Share price: $88
• Market value: $15.1 billion
• Revenue: $1.0 billion
• Net income: -$0.2 billion
• Est. 2017 earnings growth: Not meaningful
• P/E ratio: Not meaningful

Among drugmakers, BioMarin Pharmaceutical should flourish as a leader in treatments for rare genetic diseases. The company sells medicines for illnesses such as Morquio A syndrome (a cellular disorder) and PKU (a metabolic disease), and it may win approval this year to sell a medicine for Batten disease, an often-fatal pediatric neurological disorder. Also in the works are another drug to manage PKU and a treatment for dwarfism.

Perhaps most exciting is BioMarin’s experimental gene therapy for hemophilia A, which afflicts up to one in 5,000 males worldwide. Patients with this disease now rely on infusions of blood-clotting agents to survive. BioMarin’s technology replaces a missing gene that hemophiliacs need for blood clotting, potentially reducing or eliminating regimens of injections. Although the gene-therapy product is still in early development, the firm plans to mass-produce it for more-extensive clinical trials in 2018. Credit Suisse analyst Alethia Young estimates that, if approved, the drug could eventually deliver $1 billion in annual sales, nearly as much as BioMarin’s total forecast sales of $1.3 billion in 2017.

The big risk with the stock is that BioMarin’s experimental drugs won’t pan out. If they do eventually reach the market, though, they could be worth $4 billion in annual sales, says Young. The company possesses one of “the most diversified and promising” pipelines of potential products among midsize drugmakers, she says, making the stock a buy.

Amazon.com

• Symbol: AMZN
• Share price: $823
• Market value: $391.3 billion
• Revenue: $128.0 billion
• Net income: $2.1 billion
• Est. 2017 earnings growth: 85.0%
• P/E ratio: 93

Many investors dream of winning the lottery with a small company that hits the big time. But technology giants can pay handsomely, too. Trends such as cloud computing and artificial intelligence “are reinforcing the power of the largest players,” says Kennard Allen, manager of the T. Rowe Price Science & Technology Fund. Big companies can exploit these trends, he says, and “enjoy their fruits” more than firms with fewer resources.

Leading the way is Amazon.com. Not only is it dominating online shopping, but it is also building other high-growth businesses. Amazon Web Services, its cloud-computing division, could generate $100 billion in annual sales by 2027, estimates Allen, up from $12.2 billion in 2016. Amazon is also betting on artificial intelligence: Its Alexa virtual assistant gets smarter every year, “learning” thousands more skills (well beyond shopping and home-control tasks). Topping things off are Amazon’s plans to field more package-handling robots in its warehouses and to scrap delivery trucks in favor of home-delivery drones. “I see Amazon as the biggest company in the world eventually,” says Allen, who expects the stock to double over the next five years.

Google

• Symbol: GOOGL
• Share price: $820
• Market value: $557.6 billion
• Revenue: $90.3 billion
• Net income: $19.5 billion
• Est. 2017 earnings growth: 20.0%
• P/E ratio: 20

These trends also favor Alphabet. The parent of Google is investing heavily in artificial intelligence that it hopes will manage data centers, electrical grids, homes and health care systems—and play a greater role behind the scenes of Google’s many online businesses.

Alphabet has wrapped its tentacles around the wireless industry with its Android operating system (running nearly nine in 10 mobile devices worldwide), and it is developing sensors and software for self-driving cars. Wall Street adores all this—along with Alphabet’s hefty profits—granting the company a market capitalization of $558 billion, second only to that of Apple. But Alphabet’s many products and growth prospects warrant a higher stock price, says Credit Suisse, which sees the shares hitting $1,100 over the next 12 months.

Microsoft

• Symbol: MSFT
• Share price: $65
• Market value: $502.7 billion
• Revenue: $85.7 billion
• Net income: $23.0 billion
• Est. 2017 earnings growth: 16.0%
• P/E ratio: 39

Sure, it’s been around a long time. But Microsoft has generated immense sales and profits from its Windows operating systems and applications software, which run on more than 90% of the world’s personal computers.

Microsoft is now plowing that cash into high-growth areas, such as its thriving cloud-computing business (Azure), a new machine-learning division, and products for the Internet of Things. All told, Microsoft should benefit from most of the major tech trends, says Bank of America Merrill Lynch.